BioPhausia (OTC products) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
BioPhausia (OTC products) General Information
Description
A portfolio of OTC products comprising of novalucol, novalucid, c-vimin and resulax brands.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Commercial Products
Acquirer
Primary Office
- Blasieholmsgatan 2
- 111 48 Stockholm
- Sweden
BioPhausia (OTC products) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioPhausia (OTC products) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|